The Full Wiki

Iron supplements: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Iron supplements are supplements that can be prescribed by a doctor for a medical reason. Iron can also be a dietary supplement, which can be purchased in supermarkets etc. These 2 categories should not be confused.

The first iron pills were commonly known as Blaud's pills, which were named after P. Blaud of Beaucaire, the French physician who introduced and started the use of these medications as a treatment for patients with anemia.[1]



Iron supplements are used in medicine to treat iron-deficiency anemia.

First, it must be clear that iron deficiency and not another factor (e.g. chronic, low-grade, undetected blood loss such as fecal occult blood) causes the anemia. Preventive measures must be discussed with the patient (for example when the patient is on a strict vegetarian diet because inorganic iron in plants has a lower bioavailability, or elderly patients with a poor diet).

Another indication for giving extra iron is the second and third trimester of pregnancy, generally in association with folic acid. Indeed, in some condition like growth, menstruation and pregnancy, the body's need for iron is increased. Supplements may be needed to reach RDA life goals.[2]


Iron can be supplemented using various pharmacological forms, such as iron(II) sulfate (this is the most common and cheapest salt, e.g. Feratab, Fer-Iron, Slow-FE,…) and in complex with gluconate, dextran, carbonyl iron, and other salts. Sometimes ascorbic acid is added for better absorption.

Generally, iron supplementation therapy is an oral therapy, and parenteral iron therapy (intravenously or intramuscular) is only given when oral therapy has failed or oral absorption is seriously compromised (by illnesses, or when the patient cannot swallow) and benefit from oral therapy cannot be expected. Parenteral therapy is more expensive and has increased morbidity. In cases of persistent iron deficiency (renal replacement therapy, inflammatory bowel disease), the benefits of parenteral iron far outweigh the risks.

Heme iron polypeptide can be used when regular iron supplements such as ferrous sulfate or ferrous fumarate are not tolerated or absorbed. A clinical study demonstrated that HIP increased serum iron levels 23 times greater than ferrous fumarate on a milligram-per-milligram basis.[3]

Since iron stores in the body are generally depleted, and there is a limit to what the body can process (about 100mg per day) without iron poisoning, this is a chronic therapy which may take 3-6 months. In some conditions (e.g. after gastrectomy), in which production of intrinsic factor by the parietal cells of the stomach is decreased, permanent iron substitution may be necessary.

Patients at risk of acute complications may be candidates for transfusion. Patients with anemia of chronic disease may benefit from erythropoietin.

Side effects

Side effects of therapy with iron are most often diarrhea or constipation and epigastric abdominal discomfort. Taken after a meal, side effects decrease but there is an increased risk of interaction with other substances. Side effects are dose-dependent, and the dose may be adjusted.

The patient may notice that his/her stools become black. This is completely harmless, but patients must be warned about this to avoid unnecessary concern. When iron supplements are given in a liquid form, teeth may reversibly discolor (this can be avoided through the use of a straw). Intramuscular injection can be painful, and brown discoloration may be noticed.

When haematopoiesis resumes, other essentials for this process (such as folic acid or vitamin B12) may be depleted, and care must be taken to avoid deficiencies of these elements.[Citation needed]

Treatments with iron(II) sulfate have higher incidence of adverse events than iron(III)-hydroxide polymaltose complex (IPC)[4][5][6] or iron bis-glycinate chelate.[7][8]


Documented hypersensitivity and anemias without proper work-up (i.e., documentation of iron deficiency). Hypersensitivity reactions can be very dramatic if iron is administered intravenously.


Iron forms an insoluble complex with several other drugs, resulting in decreased absorption of both iron and the other drug. Examples include tetracycline, penicillamine, methyldopa, levodopa, bisphosphonates and quinolones. The same can occur with elements in food, such as calcium. Absorption of iron is better at a low pH (an acid environment), and resorption is decreased if there is a simultaneous intake of antacids, phosphates, etc.

Tannins from foods, such as tea and saw palmetto, reduce absorption of iron.

Taken after a meal, there are fewer side effects but there is also less absorption because of interaction and pH alteration. Generally, an interval of 2-3h between the iron intake and that of other drugs seems advisable.


Children who ingest tablets may become intoxicated, in which case they should be taken to an emergency department. Some formulations (like carbonyl-iron) may be safer.


Follow-up is needed to ensure compliance and to detect adequate response to therapy. If not, this may indicate another cause of anemia. Haematocrit, reticulocyte percentage, MCV, MCH and MCHC (the latter three being signs of microcytic anemia) should increase.


  1. ^ Robinson, Victor, Ph.C., M.D. (editor) (1939). "P. Blaud of Beaucaire, Blaud's Pills for Anemia, Iron pills, Iron". The Modern Home Physician, A New Encyclopedia of Medical Knowledge. WM. H. Wise & Company (New York).  , page 435.
  2. ^ Dietary Supplement Fact Sheet: Iron - U.S. National Institutes of Health, Office of Dietary Supplements.
  3. ^ Seligman, et al., Nutritional Research 2000; Vol. 20, No 9:1279-1286.
  4. ^ Geisser P (2007). "Safety and efficacy of iron(III)-hydroxide polymaltose complex / a review of over 25 years experience". Arzneimittelforschung 57 (6A): 439–52. PMID 17691594.  
  5. ^ Toblli JE, Brignoli R (2007). "Iron(III)-hydroxide polymaltose complex in iron deficiency anemia / review and meta-analysis". Arzneimittelforschung 57 (6A): 431–8. PMID 17691593.  
  6. ^ Saha L, Pandhi P, Gopalan S, Malhotra S, Saha PK (2007). "Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulfate in the treatment of iron deficiency anemia in pregnant women". MedGenMed 9 (1): 1. PMID 17435611.  
  7. ^ Szarfarc SC, de Cassana LM, Fujimori E, Guerra-Shinohara EM, de Oliveira IM (2001). "Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women". Arch Latinoam Nutr 51 (1 Suppl 1): 42–7. PMID 11688081.  
  8. ^ Ashmead SD (2001). "The chemistry of ferrous bis-glycinate chelate". Arch Latinoam Nutr 51 (1 Suppl 1): 7–12. PMID 11688084.  

See also

Got something to say? Make a comment.
Your name
Your email address